SRX Health Completes $7.3 Million Financing Led by Insiders and Existing Investors and Announces Financial Commitment of Up to $50 Million

Core Viewpoint - SRx Health Solutions, Inc. has successfully closed a $7.3 million convertible note financing and secured a $50 million equity line of credit, significantly strengthening its balance sheet and providing additional working capital for growth initiatives [1][2] Financing Details - The $7.3 million financing was led by insiders and existing investors, marking a pivotal milestone in the company's transformation into a leading North American healthcare provider [1][2] - The $50 million equity line of credit (ELOC) provides the company with the option to pursue accretive M&A opportunities in the U.S. while scaling its specialty pharma platform in Canada [2] Strategic Focus - The combined proceeds from the financing will support SRx Health's acquisition pipeline in the U.S., enhance its Canadian specialty pharma footprint, and invest in next-generation capabilities to improve patient access and operational efficiency [2][3] - SRx Health operates as an integrated healthcare services provider within the specialty healthcare industry, with a network that spans all ten Canadian provinces [3]